Stockscreener 앱 받기
23.42
0.52%
0.12
시간 외 거래:
23.41
-0.01
-0.04%
전일 마감가:
$23.30
열려 있는:
$23.54
하루 거래량:
464.75K
Relative Volume:
0.62
시가총액:
$1.73B
수익:
$425.13M
순이익/손실:
$271.17M
주가수익비율:
7.6654
EPS:
3.0553
순현금흐름:
$195.80M
1주 성능:
+3.67%
1개월 성능:
+2.00%
6개월 성능:
+28.89%
1년 성능:
+30.55%
1일 변동 폭
$23.11
$23.63
1주일 범위
$22.51
$23.63
52주 변동 폭
$16.52
$25.14
Innoviva Inc Stock (INVA) Company Profile
명칭
Innoviva Inc
전화
(650) 238-9600
주소
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, REGN, ARGX, ALNY, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
23.42 | 1.73B | 425.13M | 271.17M | 195.80M | 3.0553 |
VRTX
Vertex Pharmaceuticals Inc
|
447.26 | 113.44B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
777.25 | 81.68B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
743.12 | 45.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.73 | 43.88B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
165.01 | 35.25B | 606.42M | -1.28B | -997.58M | -6.403 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-17 | 개시 | BTIG Research | Buy |
| 2025-09-30 | 개시 | Goldman | Sell |
| 2025-08-11 | 개시 | Oppenheimer | Outperform |
| 2025-07-14 | 개시 | H.C. Wainwright | Buy |
| 2025-07-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-06-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-07-20 | 개시 | Goldman | Neutral |
| 2017-11-20 | 개시 | Deutsche Bank | Hold |
모두보기
Innoviva Inc 주식(INVA)의 최신 뉴스
INVA PE Ratio & Valuation, Is INVA Overvalued - Intellectia AI
Earnings Report: Is Innoviva Inc likely to announce a buyback2026 Sector Moves & Verified Chart Pattern Signals - baoquankhu1.vn
Aug Levels: Will Innoviva Inc stock hit new highs in YEAR2026 Review & Fast Gain Stock Trading Tips - baoquankhu1.vn
Price-Driven Insight from (INVA) for Rule-Based Strategy - Stock Traders Daily
Working capital per share of Innoviva, Inc. – BX:HVE - TradingView
Book value per share of Innoviva, Inc. – BX:HVE - TradingView
Aug Mood: Should I invest in Innoviva Inc before earningsDollar Strength & Daily Entry Point Trade Alerts - baoquankhu1.vn
Net current asset value per share of Innoviva, Inc. – BX:HVE - TradingView
INVA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Innoviva (INVA) files 10-K/A adding Armata audited financials and new officer certifications - Stock Titan
Vanguard discloses 0% Innoviva holding (NASDAQ: INVA) - Stock Titan
INNOVIVA PB Ratio: 1.44 — 30% Below Median - GuruFocus
Risk Recap: What is the next catalyst for Innoviva IncBuy Signal & Daily Oversold Bounce Ideas - baoquankhu1.vn
Retail Trends: Is Innoviva Inc impacted by rising rates2026 Rallies & AI Enhanced Execution Alerts - baoquankhu1.vn
Innoviva (NASDAQ: INVA) ties big 2026 equity plan to strong 2025 results - Stock Titan
Innoviva, Inc. (NASDAQ:INVA) Receives Consensus Rating of "Moderate Buy" from Analysts - marketbeat.com
Is It Time To Revisit Innoviva (INVA) After Strong Multi Year Share Price Gains - Yahoo Finance
Oliver Luxxe Assets LLC Invests $1.69 Million in Innoviva - National Today
Oliver Luxxe Assets LLC Makes New $1.69 Million Investment in Innoviva, Inc. $INVA - MarketBeat
Aug Levels: Is Innoviva Inc likely to announce a buybackWeekly Stock Recap & Consistent Profit Trade Alerts - baoquankhu1.vn
Innoviva spotlights subgroup analysis from ATHOS-3 trial on thromboembolic events - Traders Union
Innoviva (NASDAQ:INVA) Stock Crosses Above Two Hundred Day Moving AverageHere's Why - MarketBeat
(INVA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Innoviva, Inc. (INVA): A bull case theory - MSN
Assessing Innoviva (INVA) Valuation After Strong Earnings Growth And Portfolio Expansion - Sahm
Forecast Cut: Whats the RSI of Innoviva Inc stockWeekly Trend Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
How Investors May Respond To Innoviva (INVA) Surging EPS From Continuing Operations - simplywall.st
Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation’s 2026 Antimicrobial Resistance Benchmark Report - Weekly Voice
Day Trade: Is Innoviva Inc a stock for growth or value investorsMarket Volume Report & Fast Gain Swing Alerts - baoquankhu1.vn
(INVA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Quantbot Technologies LP Lowers Stake in Innoviva, Inc. $INVA - MarketBeat
American Century Companies Inc. Boosts Stake in Innoviva, Inc. - National Today
American Century Companies Inc. Buys 284,253 Shares of Innoviva, Inc. $INVA - MarketBeat
Analysts Offer Predictions for Innoviva FY2027 Earnings - MarketBeat
Vanguard Group Inc. Sells 81,916 Shares of Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. $INVA Shares Bought by Royce & Associates LP - MarketBeat
HC Wainwright Has Bearish Forecast for Innoviva Q1 Earnings - MarketBeat
CVRX,INVA Dividends - Finviz
Innoviva, Inc. (INVA) Stock Analysis: With A 45% Potential Upside, Is It Time To Buy? - DirectorsTalk Interviews
Analysts Offer Insights on Healthcare Companies: Cybin (HELP), Twist Bioscience (TWST) and Innoviva (INVA) - The Globe and Mail
Profit Recap: Will Innoviva Inc benefit from current market trendsTrade Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn
INNOVIVA INC (NASDAQ:INVA) Emerges as a High-Growth Momentum Pick Using Minervini's Trend Template - ChartMill
Innoviva’s 2025 Earnings and NUZOLVENCE Launch Might Change The Case For Investing In Innoviva (INVA) - simplywall.st
INVA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Innoviva CEO Details 3-Part Growth Plan, $125M Buyback, and 2026 Catalysts at Oppenheimer Conference - Defense World
INVA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31Here's Why - Bitget
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31 – Here’s Why - Insider Monkey
Is It Time To Reassess Innoviva (INVA) After Its Strong Multi Year Share Price Run - Yahoo Finance
Is It Too Late To Consider Innoviva (INVA) After Its Strong Multi‑Year Share Price Run? - simplywall.st
Innoviva (INVA) One Off Gain Driven 65.9% Margin Challenges Bullish Earnings Narratives - Sahm
Innoviva Inc (INVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.52%
0.51%
자본화:
|
볼륨(24시간):